Fri, Dec 19, 2014, 11:07 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

tennisoutofgas 1 post  |  Last Activity: Nov 11, 2014 8:34 AM Member since: Dec 20, 2002
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • tennisoutofgas by tennisoutofgas Nov 11, 2014 8:34 AM Flag

    If this RSV news gets your interest I suggest you look at NVAX. They are far ahead of everybody else working on this issue. They are in clinic already in pregnant mothers, elderly, and just a few days ago started a clinical in pediatric patients. It works, it is safe, and will be approved far before any other company will be. Also will be starting ebola clinicals in December. They can produce millions of doses a month, and will most likely get approval very quickly. Phase 1 trial might even be strong enough to get approval based on the dire need for a vaccine. Not pumping, just stating the facts.

6.11-4.7400(-43.69%)Dec 19 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.